Navigation mit Access Keys

Search


SNSF Advanced Grant for Peter Scheiffele

In response to last year’s call for SNSF Advanced Grants 232 researchers submitted applications. 24 of these projects were awarded the Swiss National Science Foundation grant, totaling 50 million Swiss francs in funding.…


Venture Kick support for Biozentrum spin-off Aukera Therapeutics

It was only at the beginning of the year that the Biozentrum spin-off Aukera Therapeutics qualified for the BaseLaunch Accelerator program. Now the two young entrepreneurs Dr. Stefan Imseng and Dr. Dritan Liko can add…


"AntiResist": Biozentrum heads a new National Center of Competence in Research for antibiotics and antibiotic resistance

The objectives of the National Center of Competence in Research (NCCR) "AntiResist" are to search for new antibiotics and to develop alternative strategies to combat antibiotic-resistant pathogens. "AntiResist" is one of a…


Aukera Therapeutics qualifies for BaseLaunch funding program

The Biozentrum start-up Aukera Therapeutics was selected to join the BaseLaunch Accelerator Program. With its qualification for this program, the biotech venture receives funding of up to 500,000 Swiss francs as well as…


Marek Basler received renowned Friedrich Miescher Award

This year, the Life Sciences Society LS2 honors the infection biologist Prof. Marek Basler from the Biozentrum, University of Basel, for his fundamental work on the structure and function of a bacterial injection apparatus -…


Development of a novel class of antibiotics

A number of pathogens protect themselves with an outer membrane that makes it difficult to combat them with antibiotics. In addition, the widespread use of antibiotics promotes the development of resistant bacteria. In…


Sanofi-Institut Pasteur International Junior Award for Marek Basler

The distinguished jury announced that Prof. Marek Basler from the Biozentrum, University of Basel, will receive the Sanofi-Institut Pasteur International Junior Award this year together with Prof. Ido Amit, Weizmann…


T3 Pharma: Bacterial cancer treatment on the path to enter clinical phase

According to T3 Pharmaceuticals (T3 Pharma), the funds of more than 25 million Swiss francs will be used primarily to progress the lead candidate through early clinical studies. The clinical trial in patients with solid…


Biozentrum Lecture with Bonnie L. Bassler

Biofilm formation, the production of light in deep-sea fish or the release of virulence factors – all these different kinds of “social” behavior rely on the communication skills of bacteria. The finding that bacteria “talk”…


Flavio Donato awarded ERC Starting Grant

The European Research Council (ERC) recently announced that Prof. Flavio Donato is one of 408 young top researchers to receive one of the much coveted grants. According to the ERC, a total of 621 million euros have been…